Cargando…
Immune response elicited in the tumor microenvironment upon rMV‐SLAMblind cancer virotherapy
Oncolytic virotherapy is a promising therapy for cancer. We previously established a recombinant measles virus (rMV‐SLAMblind) that targets NECTIN4‐expressing cancer cells and demonstrated its antitumor effects using a xenograft model in an immunodeficient mouse. In the current study, to investigate...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154881/ https://www.ncbi.nlm.nih.gov/pubmed/36715555 http://dx.doi.org/10.1111/cas.15740 |